Follow the 압타머사이언스 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 압타머사이언스 has recorded 3 insider filings. Market capitalisation: €58bn. The latest transaction was filed on 22 April 2026 (Purchase). Among the most active insiders: Wellnew&Co.. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Aptamer Science 是一家医疗保健和制药领域的公司,在 XKRX 市场上市。它专注于开发基于适体的各种疾病疗法。